"Designing Growth Strategies is in our DNA"

Inhaled Nitric Oxide (NO) Delivery Systems Market Size, Share & Industry Analysis, By Application (Adult, Infant), By Type (General, Intelligent), By End-User (Hospitals, Clinics, Specialty Centres, Others) and Regional Forecast, 2019-2026

Region : Global | Report ID: FBI103108 | Status : Ongoing

 

KEY MARKET INSIGHTS

Inhaled Nitric Oxide (NO) Delivery Systems are devices used for deliverng nitric oxide in paients experiencing severe breathing problems. Nitric oxide is clinically efficient  in dilating bloood vessels and to relax muscle tension in order to abosrb oxgen efficiently in the body. Additionally, the nitric oxide delivery systems are also used to treat hypoxic respiratory failure in infants. Focus of key players to launch technologically advanced NO delivery systems combined with the rise of respiratory diseases are estimated to bolster the market growth in the coming years. For example, in January 2020, Vero Biotech LLC received U.S FDA clearance for GENOSYL inhaled nitric oxide gas delivery system.


Increase in the incidence and prevalence of respiratory disease are estimated to fuel the inhaled nitric oxide (NO) market growth over the forecast duration. In addition to this increase outbreak of respiratory infections like SARS, COVID-19 among others is further projected to drive the NO delivery systems market. As of May 2020, around 1.8 million people are affected with coronavirus in the U.S. Moreover, the U.S FDA has permitted the emergency use of GENOSYL NO delivery system manufactured by VERO Biotech in critical COVID-19 patients suffering from respiratory failure. These trends are expected to surge the demand of inhaled nitric oxide delivery systems in the country.


Key Market Driver -

Growing prevalence of pulmonary hypertension and hypoxic respiratory failures

Key Market Restraint -

Recent product recalls of inhaled nitric oxide delivery systems


However, product recalls of inhaled nitric oxide delivery systems are estimated to restrain the market growth in the coming years. For instance, in November 2016, Mallinckrodt Pharmaceuticals has to recall INOmax DSIR Plus delivery system owing to defective valve calibration of the manometer. The U.S FDA classified the recall as Class 2 device recall.


Market Segmentation:


Globally, the inhaled nitric oxide (NO) delivery systems market can be categorized on the basis of application, type, end-user and region. Based on the application, the market can be segmented into adult and infant. Based on the type, the market can be bifurcated into intelligent and general. Based on the end-users the market can be segmented into hospitals, clinics, specialty centres, and others.


Geographically, the inhaled nitric oxide (NO) delivery systems market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.


Key Players Covered:


Some of the major companies that are present in the inhaled nitric oxide (NO) delivery systems market are VERO Biotech LLC, International Biomedical, Bellerophon Therapeutics, Mallinckrodt Pharmaceuticals, Praxair, Inc., SLE, Getinge AB, and other prominent players.


Key Insights:



  • Prevalence of Respiratory Disease  by Key Countries/Region

  • Technological Advancements in Inhaled Nitric Oxide Delivery Systems Market by Key Countries/Region

  • Introduction of New Products/Approvals (By Major Players)

  • Key Industry Developments Mergers, Acquisitions, and Collaborations


Regional Analysis:


To gain extensive insights into the market, Request for Customization


Based on geographical segmentation, the inhaled nitric oxide (NO) delivery systems market can be categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North American region is projected to hold the leading position in the market and is anticipated to follow the same impetus over the forecast duration. This growth of the market can be owing to the higher awareness regarding respiratory illness and disorders combined with refined healthcare infrastructure in the region. Moreover, increase in the prevalence of the chronic diseases and availability & high adoption of technologically advanced products are also driving the market in this region. Introduction of advanced NO delivery systems in the region is also estimated to aid the market growth. In August 2019, Beyond Air announced the development of LungFit PH, an innovative cylinder free NO delivery system for patients suffering from pulmonary hypertension. Europe is projected to be the second most dominant market throughout the analysis duration. The factors such as increases in the prevalence of chronic diseases, and rise in geriatric population and adoption of innovative medical devices is projected to drive the inhaled nitric oxide (NO) delivery systems market growth in this region. However, the countries of Asia-Pacific region is likely to expand at comparatively higher growth rate in near future. The growth of the market can be attributed to the increase in respiratory failure, outbreak of respiratory infections and rise in geriatric population. The Latin America and the Middle East and Africa markets are expected to expand at a moderate rate during the forecast period.


Segmentation


























 ATTRIBUTE 


  DETAILS

By Application




  • Adult

  • Infant



By Type




  • General

  • Intelligent



By End-User




  • Hospitals

  • Clinics

  • Specialty Centres

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



Inhaled Nitric Oxide (NO) Delivery Systems Market Industry Developments



  • In March 2020, Mallinckrodt Pharmaceutical received approval from the regulatory authorities of Canada to use the company’s NO delivery systems for COVID-19 patients

  • In March 2020, the U.S FDA approved the emergency expanded use of inhaled nitric oxide delivery system manufactured by Bellerophon Therapeutics for the management of respiratory failure in COVID-19 patients.


Inhaled Nitric Oxide (NO) Delivery Systems Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2019
  • 2016-2018

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

baxter
novo-nordisk
Bio-Rad
lpsos
Sedana-Cyan-Black-Tag

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X